Mdma molecule:

Image from PubChem

Mdma Clinical Trials


Identifying Optimal Psychosocial Interventions for Patients Receiving Office-Based Buprenorphine


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04257214

Organisation Name: Philadelphia College of Osteopathic Medicine

Overal Status: Recruiting

Start Date: July 15, 2020

Last Update: October 8, 2020

Lead Sponsor: Philadelphia College of Osteopathic Medicine

Brief Summary: Current clinical guidelines for medication assisted treatment (MAT) of opioid use disorder (OUD) recommend that treatment include a psychosocial component to help address psychological factors related to addiction. However, a knowledge gap exists regarding the most effective forms of psychosocial intervention and what interventions are most effective for different types of patients. This gap represents a significant barrier to the widespread implementation of effective office-based opioid treatment (OBOT) with buprenorphine, which is important to improving opioid treatment and responding to the critical needs of individuals living with OUD. The overarching goal of this patient-centered research is to address the diverse needs and preferences of OUD patients in regards to psychosocial approaches and to overcome the "one-size-fits-all" strategies that are typically used to treat OUD. Importantly, investigators arrived at this goal, in part, through collaboration and consultation with former patients who have received different types of treatments for OUD. In this manner, patients provided important insight to inform the selection of interventions to be evaluated, patient characteristics that may differentially impact the effects of the interventions, and the patient outcomes to be examined.

Conditions:
  • Opioid Use Disorder


Total execution time in seconds: 0.35264897346497